Rhinozyn®

Key marketing aspects

• targeting the most frequent allergic disease
• unique combination of patented probiotic strains selected for the treatment of allergic rhinitis and for restoring the allergic immune system
• plus vitamin D – health claim related to the normal function of the immune system and inflammatory response
• reducing both eye and nasal symptoms in perennial rhinitis
• improving quality of life during allergy season (even in subjects using pharmacotherapy)
• natural alternative to pharmacotherapy or add-on to antihistaminic
• clinically tested in children & adults
• most efficient probiotic solution available for the treatment of allergic rhinitis
• pharmacy exclusive

Facts

• 3 randomized clinical trials published reporting improvements in a total of 305 subjects treated
• significant reduction of clinical symptoms of perennial rhinitis
• compelling improvement of quality of life (RQLQ) in seasonal rhinitis
• stimulating the Th1 immune response and reducing IgE synthesis
• vitamin D modulates the immune response and is associated with aeroallergen sensitization and allergic rhinitis
• highest clinical efficacy amongst probiotic treatments for allergic rhinitis

Conclusion

• significant evidence of beneficial clinical effects of Rhinozyn^® in the treatment of allergic rhinitis
• adjunctive therapy with Rhinozyn^® can be recommended for the treatment of allergic rhinitis
• meta analysis proves Rhinozyn^® to be the leading probiotic treatment for allergic rhinitis